Oxyphyllenodiol BCAS# 363610-32-6 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
| Cas No. | 363610-32-6 | SDF | Download SDF |
| PubChem ID | N/A | Appearance | Oil |
| Formula | C14H22O3 | M.Wt | 238.36 |
| Type of Compound | Sesquiterpenoids | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
Oxyphyllenodiol B Dilution Calculator
Oxyphyllenodiol B Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 4.1953 mL | 20.9767 mL | 41.9533 mL | 83.9067 mL | 104.8834 mL |
| 5 mM | 0.8391 mL | 4.1953 mL | 8.3907 mL | 16.7813 mL | 20.9767 mL |
| 10 mM | 0.4195 mL | 2.0977 mL | 4.1953 mL | 8.3907 mL | 10.4883 mL |
| 50 mM | 0.0839 mL | 0.4195 mL | 0.8391 mL | 1.6781 mL | 2.0977 mL |
| 100 mM | 0.042 mL | 0.2098 mL | 0.4195 mL | 0.8391 mL | 1.0488 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Demethoxysudachitin
Catalog No.:BCX0521
CAS No.:4323-80-2
- Isodihydroauroglaucin
Catalog No.:BCX0520
CAS No.:74886-31-0
- 4-Hydroxyphenylpyruvic acid
Catalog No.:BCX0519
CAS No.:156-39-8
- Sanggenon F
Catalog No.:BCX0518
CAS No.:85889-03-8
- Tetrahydroauroglaucin
Catalog No.:BCX0517
CAS No.:40434-07-9
- 5,4'-Dihydroxy-6,7,8,3'-tetramethoxyflavone
Catalog No.:BCX0516
CAS No.:16520-78-8
- 5,7-Dihydroxy-3,8,3',4'-tetramethoxyflavone
Catalog No.:BCX0515
CAS No.:42923-42-2
- Xanthomicrol
Catalog No.:BCX0514
CAS No.:16545-23-6
- N-Acetyl-D-mannosamine
Catalog No.:BCX0513
CAS No.:7772-94-3
- N-acetyl-D-galactosamine
Catalog No.:BCX0512
CAS No.:1811-31-0
- D-Galactosamine hydrochloride
Catalog No.:BCX0511
CAS No.:1772-03-8
- D-Mannosamine hydrochloride
Catalog No.:BCX0510
CAS No.:5505-63-5
- Labda-12E,14-dien-16,15-olid-17-oic acid
Catalog No.:BCX0523
CAS No.:1855905-16-6
- Butyl rosmarinate
Catalog No.:BCX0524
CAS No.:222713-83-9
- Dihydroauroglaucin
Catalog No.:BCX0525
CAS No.:77102-91-1
- (E)-5-Hydroxy-6-isoprenyl-2-(pent-1-en-1-yl)benzofuran-4-carbaldehyde
Catalog No.:BCX0526
CAS No.:916602-30-7
- 5-(1-Hydroxypropan-2-yl)-2-methylphenol
Catalog No.:BCX0527
CAS No.:111044-80-5
- 5,7,4'-Trihydroxy-3,8-dimethoxyflavone
Catalog No.:BCX0528
CAS No.:14965-09-4
- 4-Hydroxythonningianin B
Catalog No.:BCX0529
CAS No.:2329726-95-4
- 2-Hydroxymethyl-5-isopropylphenol
Catalog No.:BCX0530
CAS No.:111044-81-6
- Salcolin A
Catalog No.:BCX0531
CAS No.:1977557-69-9
- 1β,8α-Dihydroxyeremophila-7(11),9-dien-12,8-olide
Catalog No.:BCX0532
CAS No.:849700-44-3
- 13-Hydroxynootkatone
Catalog No.:BCX0533
CAS No.:141695-86-5
- 1-O-Caffeoyl-3,4-di-O-galloyl-β-D-glucopyranose
Catalog No.:BCX0534
CAS No.:359819-46-8
Integrated UPLC-MS/MS and UHPLC-Q-orbitrap HRMS Analysis to Reveal Pharmacokinetics and Metabolism of Five Terpenoids from Alpiniae oxyphyllae Fructus in Rats.[Pubmed:33334283]
Curr Drug Metab. 2021;22(1):70-82.
BACKGROUND: Alpiniae oxyphyllae Fructus (AOF), a traditional Chinese medicine (TCM), is widely used in the treatment of urinary, gastrointestinal and neurologic diseases in China. Although terpenoids are the main active ingredients of AOF, there are few researches on their pharmacokinetics and metabolism. METHODS: In this study, a sensitive, rapid, accurate and novel ultra high performance liquid chromatography tandem mass spectrometry (UPLC-MS/MS) method was established to evaluate the pharmacokinetic behavior of five terpenoids (Oxyphyllenodiol B, (4S*,5E,10R*)-7-oxo-tri-nor-eudesm-5-en-4beta-ol, 7-epi-teucrenone, (+)- (4R,5S,7R)-13-hydroxynootkatone, (E)-labda-12,14-dien-15(16)-olide-17-oic acid) in rats after oral administration of AOF extracts. 27 metabolic metabolites of the five terpenoids were identified by ultra high performance liquid chromatography -Q Exactive hybrid quadrupole-orbitrap high-resolution accurate mass spectrometry (UHPLC-Q-Orbitrap HRMS) based on precise mass and fragment ions. RESULTS: The established pharmacokinetic analysis method showed good linearity over a wide concentration range, and the lower quantitative limit (LLOQ) ranged from 0.97 to 4.25 ng/mL. Other validation parameters were within the acceptable range. In addition, 27 metabolites were identified in plasma, urine and feces samples, and the metabolic pathways of five terpenoids were mainly focused on glucoside conjugation, dehydration, desaturation and glycine conjugation. CONCLUSION: This is the first study on the pharmacokinetics and metabolism of five terpenoids in AOF, illuminating the disposal process of terpenoids in vivo. It was expected that the results of this study would provide some references for the apprehension of the action mechanism and the further pharmacological study of five terpenoids in AOF.
Sesquiterpenes and butenolides, natural anti-HIV constituents from Litsea verticillata.[Pubmed:15931585]
Planta Med. 2005 May;71(5):452-7.
In a continuing investigation, six sesquiterpenes, as well as five butenolides were isolated from the leaves and twigs of Litsea verticillata Hance (Lauraceae). Among the isolates, three were determined to be new sesquiterpenes: isolitseanes A (1), B (2) and C (3); three known sesquiterpenes were identified as Oxyphyllenodiol B (4), 1,2,3,4-tetrahydro-2,5-dimethyl-8-(1-methylethyl)-1,2-naphthalenediol (5), and chromolaevanedione (6). The butenolides include the novel litseabutenolide (9) and four known compounds: 3- epi-litsenolide D2 (7), cis-listenolide D1 (8), 4-hydroxy-2-methylbut-2-enolide (10), and hydroxydihydrobovolide (11). Isolates 2, 4, 5, 7, 9, 10 and 11 were found to inhibit HIV-1 replication in a green fluorescent protein (GFP)-based reporter cell line (HOG.R5) with IC50 values of 38.1, 54.6, 91.0, 9.9, 40.3, 129.8, and 122.7 microM, respectively. Structure elucidation and identification were based on spectroscopic means including 1D and 2D NMR analyses.
